Sucampo Pharmaceuticals, Inc. (SCMP)

[H2R]

Growth EPS Projections:
'15 '16 '17
48.3% 32.9% 67.1%

With a P/E of about 38 and great stats (RoE, RoA, Profit, etc...) besides that. What a Peter Lynch type buy (great company with a great PEG). And they meet the projections well enough! An expensive company but in this context, I'm keeping it :)

A dip then (a bad one; was due to a downgrade by one analyst I would gather), a great Hold for a long time in my view. Of course, no crystal ball here.